PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Research shows positive results with high pressure technology for certain dairy products

Research shows positive results with high pressure technology for certain dairy products
2010-12-23
(Press-News.org) The AZTI-Tecnalia technological centre, in a project undertaken by the Tecnolat and Llet de Catalunya dairy product companies within the FUTURAL project, has verified that, as an alternative to the traditional heat treatment for decontamination of a number of dairy products, high pressure technology is highly recommendable. In fact, according to a press release from Tecnolat, the results, especially with ready-to-eat fruit products and in the inactivation of moulds and yeasts in other dairy products, "were highly positive and promising".

The research and trials carried out by AZTI-Tecnalia showed that, for example, sweetened ready-to-eat fruit products, once subjected to various high pressure treatments at different intensities, showed a total inactivation of the bacteria analysed. In this case the technology also showed itself to be a good technique for conservation, given that the progress of the treated samples was optimum, microbian growth not being observed throughout their useful life.

The trials also showed the effectiveness of this technology in the inactivation of specific moulds and yeasts in dairy foods. Once processed with high pressure, it was observed that the treated samples not only conserved their properties and characteristics of quality throughout their useful life (estimated to be three months) but also, sensorially - the products treated with high pressure tasted better than the traditional (heat treated) samples.

The project has acted to optimise the most suitable high pressure treatment for obtaining the usual ingredients in the dairy industry, as an alternative to traditional heat treatment, thus obtaining products with longer useful life and with practically intact organoleptic characteristics.

High pressure technology

High pressure processing is a technology of conservation which is an alternative to conventional heat treatment. Its particular characteristics make it such that it can develop and market food products which are not only innovative, but also have excellent hygiene quality and less affected sensorial qualities.

The High Pressure team subjected the food to high pressure - up to 6,000 bars -, which resulted in the inactivation of most altering or pathogenic micro-organisms. This would be the equivalent of pasteurisation, but modifying the properties of the food much less than using traditional treatment. Moreover, this technology can enable the prolongation of its useful life, affecting the sensorial quality of the food less than conventional heat treatment.

It should be pointed out that AZTI-Tecnalia has a pilot plant with 55 L equipment – the only one at world level for developing fresher, sterilised products, given that this equipment enables combining high pressures and high temperatures, while minimising heat treatment. This new technology, recognised by the USDA in the United States as an alternative for obtaining stable products with low acidity at ambient temperature; is also known as pressure-assisted thermal sterilisation.

Besides its participation in this project, AZTI-Tecnalia is working on the sterilisation of food products through applying high pressure with increases in temperature, also obtaining promising results with this new line of research.



INFORMATION:


[Attachments] See images for this press release:
Research shows positive results with high pressure technology for certain dairy products

ELSE PRESS RELEASES FROM THIS DATE:

Emerging drug class may enhance red blood cell production in anemic patients

2010-12-23
FINDINGS: By determining how corticosteroids act to increase production of red blood cell progenitors, Whitehead Institute researchers have identified a class of drugs that may be beneficial in treating some erythropoietin-resistant anemias. One such anemia is Diamond-Blackfan anemia (DBA), which is frequently treated with corticosteroids, despite their severe side-effects. The identified class of drugs may be able to treat other anemias, including those resulting from trauma, sepsis, malaria, kidney dialysis, and chemotherapy. RELEVANCE: Some common anemias can be treated ...

Researchers discover genetic predisposition for breast, kidney cancers

2010-12-23
Researchers at Cleveland Clinic's Genomic Medicine Institute have revealed multiple genetic discoveries that may permit easier diagnosis and disease management for Cowden syndrome patients who are predisposed to breast and kidney cancer. The research, which could allow for earlier discovery of cancerous tumors, is published in the Dec. 22 issue of the Journal of the American Medical Association (JAMA). Charis Eng, M.D., Ph.D, Chair of the Genomic Medicine Institute at Cleveland Clinic, led the research. It revealed KILLIN as a novel predisposition gene for Cowden ...

98.6 degrees Fahrenheit ideal temperature for keeping fungi away and food at bay

2010-12-23
December 21, 2010 — (BRONX, NY) — Two researchers at Albert Einstein College of Medicine of Yeshiva University have found that our 98.6° F (37° C) body temperature strikes a perfect balance: warm enough to ward off fungal infection but not so hot that we need to eat nonstop to maintain our metabolism. "One of the mysteries about humans and other advanced mammals has been why they are so hot compared with other animals," said study co—author Arturo Casadevall, M.D., Ph.D., professor and chair of microbiology & immunology at Einstein. "This study helps to explain why mammalian ...

Hot embossing glass -- to the nearest micrometer

Hot embossing glass -- to the nearest micrometer
2010-12-23
Projectors are getting smaller and smaller. Now that pictures are available in digital format almost everywhere, we need projectors to beam giant photos and films onto walls. Projectors contain lenses that spread the light from the pixelated source in such a way as to illuminate the image area evenly. Until now, this was done using complicated arrays of lenses placed one behind the other. Recently, the same effect has been achieved using flat lens arrays made up of thousands of identical microlenses. This kind of array takes up much less space and does not need to be painstakingly ...

Removal of hexavalent chromium from your drinking water

2010-12-23
The only way to learn if your water source has hexavalent chromium is to check with your public water supplier and request a water quality report, said NJIT Professor Taha Marhaba, a civil/environmental engineer. Most municipal or city engineers should be able to provide such a report upon request. Additional information specifically about hexavalent chromium levels may also be available. "In general, hexavalent chromium can be found in either surface or groundwater sources and its source can be either natural or man-made industrial operations that have used chromium," ...

Drilling in the holy land

2010-12-23
About 50 miles from Bethlehem, a drilling project is determining the climate and earthquake activity of the Holy Land. Scientists from eight nations are examining the ground below the Dead Sea, by placing a borehole in this deepest basin in the world. The International Continental Scientific Drilling Program ICDP brings together research teams from Israel, Japan, Norway, Switzerland, the USA and Germany. Particularly noteworthy: Researchers from Jordan and Palestine are also involved. Scientists and technicians of the GFZ German Research Centre for Geosciences have now ...

Researchers find gene that protects against dementia in high-risk individuals

2010-12-23
JACKSONVILLE, Fla. — Neuroscientists had assumed that a mutation in the progranulin gene, which makes the progranulin protein and supports brain neurons, was sufficient to produce a kind of dementia known as frontotemporal lobar degeneration (FTLD). But now an international team of scientists led by researchers at Mayo Clinic's campus in Florida have found another genetic factor they say appears to protect against the disorder in progranulin mutation carriers. In an article published in the Dec. 22, 2010, issue of Neurology, the medical journal of the American Academy ...

Scripps Research scientist uncovers switch controlling protein production

2010-12-23
JUPITER, FL, December 22, 2010 – A scientist from the Florida campus of The Scripps Research Institute has discovered a molecular switch that controls the synthesis of ribosomes. Ribosomes are the large machineries inside all living cells that produce proteins, the basic working units of any cell. These new findings offer a novel target for potential treatments for a range of diseases, including cancer. The study is published in the December 24, 2010 edition of the Journal of Molecular Biology. The study identified the molecular switch, essentially formed by a small ...

Some cancer drugs may block cellular 'cross talk' but not kill cancer cells

2010-12-23
AURORA, Colo. (Dec. 22, 2010)—A class of drugs thought to kill cancer cells may in fact block "cross talk" between the cancer cell and normal immune cells, resulting in reduced cancer growth and spread—a discovery that could significantly alter the way cancer drugs are evaluated in the future. Researchers at the University of Colorado Cancer Center demonstrated the discovery in bladder cancer, the fifth most common cancer in the United States. Bladder cancer will kill about 14,000 Americans this year, most of whom will die as a result of the disease's spread to other ...

Researchers train software to help monitor climate change

Researchers train software to help monitor climate change
2010-12-23
University Park, Pa. -- A computer program that automatically analyzes mounds of satellite images and other data could help climate scientists keep track of complex, constantly changing environmental conditions, according to an international team of researchers. "All of the data and information that is continually collected by satellites and sensors can cause tons of problems for scientists, who simply don't have the time to analyze every pixel of every satellite image," said James Wang, professor of information sciences and technology, Penn State. "Our goal has been ...

LAST 30 PRESS RELEASES:

Azacitidine–venetoclax combination outperforms standard care in acute myeloid leukemia patients eligible for intensive chemotherapy

Adding epcoritamab to standard second-line therapy improves follicular lymphoma outcomes

New findings support a chemo-free approach for treating Ph+ ALL

Non-covalent btki pirtobrutinib shows promise as frontline therapy for CLL/SLL

University of Cincinnati experts present research at annual hematology event

ASH 2025: Antibody therapy eradicates traces of multiple myeloma in preliminary trial

ASH 2025: AI uncovers how DNA architecture failures trigger blood cancer

ASH 2025: New study shows that patients can safely receive stem cell transplants from mismatched, unrelated donors

Protective regimen allows successful stem cell transplant even without close genetic match between donor and recipient

Continuous and fixed-duration treatments result in similar outcomes for CLL

Measurable residual disease shows strong potential as an early indicator of survival in patients with acute myeloid leukemia

Chemotherapy and radiation are comparable as pre-transplant conditioning for patients with b-acute lymphoblastic leukemia who have no measurable residual disease

Roughly one-third of families with children being treated for leukemia struggle to pay living expenses

Quality improvement project results in increased screening and treatment for iron deficiency in pregnancy

IV iron improves survival, increases hemoglobin in hospitalized patients with iron-deficiency anemia and an acute infection

Black patients with acute myeloid leukemia are younger at diagnosis and experience poorer survival outcomes than White patients

Emergency departments fall short on delivering timely treatment for sickle cell pain

Study shows no clear evidence of harm from hydroxyurea use during pregnancy

Long-term outlook is positive for most after hematopoietic cell transplant for sickle cell disease

Study offers real-world data on commercial implementation of gene therapies for sickle cell disease and beta thalassemia

Early results suggest exa-cel gene therapy works well in children

NTIDE: Disability employment holds steady after data hiatus

Social lives of viruses affect antiviral resistance

Dose of psilocybin, dash of rabies point to treatment for depression

Helping health care providers navigate social, political, and legal barriers to patient care

Barrow Neurological Institute, University of Calgary study urges “major change” to migraine treatment in Emergency Departments

Using smartphones to improve disaster search and rescue

Robust new photocatalyst paves the way for cleaner hydrogen peroxide production and greener chemical manufacturing

Ultrafast material captures toxic PFAS at record speed and capacity

Plant phenolic acids supercharge old antibiotics against multidrug resistant E. coli

[Press-News.org] Research shows positive results with high pressure technology for certain dairy products